News | December 18, 2014

Topera Receives Most Innovative New Product Award for 3-D Arrythmia Mapping System

Product designed to improve patient outcomes by enabling electrophysiologists to view dynamic representation of the electrical activity of the heart

EP Lab, Atrial Fibrilation, RhythmView 3-D Mapping System, MIP Award

Image courtesy of Topera

December 18, 2014 — Topera, Inc. announced that its RhythmView 3-D Mapping System received the Most Innovative New Product (MIP) Award at the 2014 CONNECT MIP Awards.

Topera’s RhythmView 3-D Mapping System received San Diego’s most prestigious honor for technology and life sciences innovation in the Pharmaceutical Drugs and Medical Devices category, based on its innovative electrophysiology platform to improve the diagnosis and treatment of complex cardiac arrhythmias including atrial fibrillation, the most common heart rhythm disorder in the world, afflicting 8 million people in the United States and Europe alone.

Topera’s 3-D analysis and mapping system assists electrophysiologists in the identification of the electrical source of complex cardiac arrhythmias. With the Topera 3-D Mapping System patient outcomes can be potentially improved by enabling electrophysiologists to view a dynamic representation of the electrical activity of the heart, supporting the diagnosis of the arrhythmia source and treatment planning for a variety of heart rhythm disorders including atrial fibrillation, atrial flutter, atrial tachycardia and ventricular tachycardia.

For a complete list of winners: wwww.connect.org

For more information: www.toperamedical.com

 

 

Related Content

Biotronik Announces U.S. Launch of Edora HF-T QP CRT Pacemaker
Technology | Cardiac Resynchronization Therapy Devices (CRT)| August 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and commercial availability of Edora HF-T QP, an...
The FDA is concerned about cybersecurity of ICDs and cyber security of other medical devices.
Feature | Cybersecurity| August 16, 2017 | Dave Fornell
There is growing concern among patients and regulators that medical devices, especially implantable electrophysiology
Three New Atrial Fibrillation Studies to Feature HeartLight Endoscopic Ablation System
News | Ablation Systems| August 07, 2017
CardioFocus Inc. announced that its HeartLight Endoscopic Ablation System is being featured in three new major clinical...
Merge Hemo cath lab hemodynamics monitoring system.

Hemodynamic data shown on screens from the Merge Hemo recording system. It is among the newer generation hemodynamic systems for cath labs that are more user friendly and have technologies to speed workflow.

Feature | Hemodynamic Monitoring Systems| August 03, 2017 | Dave Fornell
The current generation of...
Left Atrial Pressure Monitor from Vectorious Medical Technologies Offers New Hope for Heart Failure Patients

On of the top stories in July was the introduction of a left atrial pressure monitor from Vectorious Medical Technologies to prevent heart failure patient hospitalizations or readmissions. Read the article"Left Atrial Pressure Monitor Offers New Hope for Heart Failure Patients."

Feature | August 01, 2017 | Dave Fornell
Aug.
Ohio State Researchers Prove Human Heart's 'Battery' Has Multiple Backups
News | EP Lab| July 27, 2017
July 27, 2017 — There is good news when it comes to the heart’s sinoatrial node (SAN), the body’s natural...
Medtronic Announces First Enrollments in STOP AF First Clinical Trial
News | Ablation Systems| July 24, 2017
Medtronic plc recently announced first enrollments in the STOP AF First clinical trial. The trial will evaluate the...
Biotronik Launches DX Technology for U.S. Heart Failure Patients
News | Cardiac Resynchronization Therapy Devices (CRT)| July 21, 2017
Biotronik announced U.S. Food and Drug Administration (FDA) approval and availability of the Intica DX and Intica...
Overlay Init